Guidance on registration - ECHA - Europa
Guidance on registration - ECHA - Europa
Guidance on registration - ECHA - Europa
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
74<br />
<str<strong>on</strong>g>Guidance</str<strong>on</strong>g> <strong>on</strong> registrati<strong>on</strong><br />
Versi<strong>on</strong> 2.0 May 2012<br />
In additi<strong>on</strong>, for substances manufactured or imported between 1 and 10 t<strong>on</strong>nes per year for<br />
which no CSR is required, the registrant will have to provide informati<strong>on</strong> <strong>on</strong> exposure as<br />
specified under secti<strong>on</strong> 6 of Annex VI. This informati<strong>on</strong> will include at least the types of use for<br />
the substance (industrial, professi<strong>on</strong>al or c<strong>on</strong>sumer), the significant routes for human and<br />
envir<strong>on</strong>mental exposure and the pattern of exposure and will be also reported in secti<strong>on</strong> 3 of<br />
IUCLID 5.<br />
Please, note that although exposure scenario(s) (see secti<strong>on</strong> 5.3.1.2) will be attached to the<br />
IUCLID 5 file as an integral part of the CSR where the CSR is required, IUCLID 5 includes<br />
relevant fields to be filled in under secti<strong>on</strong> 3 12 .<br />
5.2.3.1 How to report the t<strong>on</strong>nage<br />
The following fields will have to be completed:<br />
Year: calendar year for which the t<strong>on</strong>nage is reported.<br />
T<strong>on</strong>nage: total t<strong>on</strong>nes per year (see secti<strong>on</strong> 2.2.6) manufactured or imported in the<br />
form of substance <strong>on</strong> its own or in mixtures, including ‘intermediate’ uses reported (see<br />
below). It should NOT include the t<strong>on</strong>nes of the substance imported in articles per year.<br />
The registrant is requested to report the t<strong>on</strong>nage for the year of submissi<strong>on</strong> of the<br />
dossier.<br />
Own use: t<strong>on</strong>nes per year used by the registrant. This should include both uses as an<br />
intermediate and as a n<strong>on</strong>- intermediate.<br />
Intermediate (<strong>on</strong>-site): t<strong>on</strong>nes per year of the substance manufactured for use as <strong>on</strong>site<br />
intermediate under strictly c<strong>on</strong>trolled c<strong>on</strong>diti<strong>on</strong>s.<br />
Intermediate (transported): t<strong>on</strong>nes per year of the substance manufactured or<br />
imported and used as intermediate under strictly c<strong>on</strong>trolled c<strong>on</strong>diti<strong>on</strong>s.<br />
If part of the t<strong>on</strong>nage is used for the purpose of PPORD and covered by a PPORD notificati<strong>on</strong> it<br />
should not be included here. If it is not covered by a PPORD notificati<strong>on</strong> it should be reported<br />
here and included in the t<strong>on</strong>nage used for the determinati<strong>on</strong> of the informati<strong>on</strong> requirements.<br />
5.2.4 Informati<strong>on</strong> requirements <strong>on</strong> intrinsic properties (Annexes VII to X)<br />
All relevant available informati<strong>on</strong> <strong>on</strong> the physicochemical, toxicological and ecotoxicological<br />
properties of the substance as specified under Annexes VII to X (and its adaptati<strong>on</strong>s according<br />
to Annex XI) have to be provided in secti<strong>on</strong>s 4 to 7 in IUCLID 5 in the form of study<br />
summaries or robust study summaries.<br />
According to REACH, robust study summaries need to be provided <strong>on</strong>ly when a chemical safety<br />
report is required, i.e. for substances above 10 t<strong>on</strong>nes per year, and <strong>on</strong>ly for key studies (see<br />
text box above). However, it is recommended to provide robust study summaries for all key<br />
studies including for substances manufactured or imported at less than 10 t<strong>on</strong>nes per year.<br />
This would facilitate the evaluati<strong>on</strong> work to be d<strong>on</strong>e by <strong>ECHA</strong> and eventually Member States in<br />
the frame of substance evaluati<strong>on</strong> and may potentially avoid the need for them to request<br />
further informati<strong>on</strong>.<br />
In additi<strong>on</strong> there might be cases where it could be useful to provide robust study summaries<br />
for n<strong>on</strong> key studies. For example, in case the key study is not the <strong>on</strong>e giving rise to the<br />
highest c<strong>on</strong>cern it might be useful to prepare a robust study summary for this study as well as<br />
for all the studies dem<strong>on</strong>strating a higher c<strong>on</strong>cern, or at least to report sufficient informati<strong>on</strong> to<br />
justify the disregard of these results so that the choice of the key study is better justified.<br />
12<br />
Fields available from IUCLID versi<strong>on</strong> 5.4 <strong>on</strong>wards.<br />
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu